Skip to content

AMAG PHARMACEUTICALS, INC.: filings

Every AMAG PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filing record ends 2020-11-06

The latest filing in this captured record is a 10-Q filed 2020-11-06. No later filing is in the SEC companyfacts record captured on 2026-09-22. AMAG PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2020-11-06fiscal Q3 2020541400000792977-20-000094
10-K/A2020-09-15fiscal FY 2019551740000792977-20-000090
10-Q2020-08-17fiscal Q2 2020481190000792977-20-000080
10-Q2020-05-11fiscal Q1 202048990000792977-20-000043
10-K2020-03-06fiscal FY 2019551660000792977-20-000027
10-Q2019-11-01fiscal Q3 2019501230000792977-19-000137
10-Q2019-08-07fiscal Q2 2019501230000792977-19-000121
10-Q2019-05-08fiscal Q1 2019501000000792977-19-000084
10-K2019-03-01fiscal FY 2018541840000792977-19-000036
10-Q2018-11-02fiscal Q3 2018451120000792977-18-000068
10-Q2018-08-03fiscal Q2 2018451120000792977-18-000053
10-Q2018-05-04fiscal Q1 201845920000792977-18-000023
10-K2018-03-01fiscal FY 2017521690000792977-18-000012
10-Q2017-11-06fiscal Q3 2017441120000792977-17-000040
10-Q2017-08-04fiscal Q2 2017441120000792977-17-000030
10-Q2017-05-03fiscal Q1 201743880000792977-17-000021
10-K2017-02-21fiscal FY 2016481630000792977-17-000007
10-Q2016-11-04fiscal Q3 2016411060000792977-16-000005
10-Q2016-08-09fiscal Q2 2016421090001558370-16-007715
10-Q2016-05-05fiscal Q1 201642850001558370-16-005360
10-K2016-02-24fiscal FY 2015451290001558370-16-003420
10-Q2015-11-06fiscal Q3 2015431150001558370-15-002383
10-Q2015-07-27fiscal Q2 2015391030001104659-15-053179
10-Q2015-05-06fiscal Q1 201539780001104659-15-034943
10-K2015-02-18fiscal FY 2014451290001047469-15-000871
10-Q2014-11-07fiscal Q3 201434920001104659-14-078033
10-Q2014-08-05fiscal Q2 201430750001104659-14-056949
10-Q2014-05-05fiscal Q1 201429620001104659-14-034303
10-K2014-02-10fiscal FY 201331970001047469-14-000718
10-Q2013-11-06fiscal Q3 201328660001104659-13-081687
10-Q2013-08-07fiscal Q2 201333820001104659-13-061018
10-Q2013-05-06fiscal Q1 201325520001104659-13-037228
10-K2013-03-04fiscal FY 201228890001047469-13-002092
10-Q2012-11-07fiscal Q3 201226640001104659-12-075430
10-Q2012-08-07fiscal Q2 201228760001104659-12-055043
10-Q2012-05-03fiscal Q1 201225520001104659-12-032490
10-K2012-03-08fiscal FY 201127690001047469-12-002297
10-Q2011-11-08fiscal Q3 201127690001104659-11-062196
10-Q2011-08-05fiscal Q2 201129710001104659-11-044029
10-Q2011-05-09fiscal Q1 201128570001104659-11-027158
10-K2011-02-25fiscal FY 201030790001047469-11-001351
10-Q2010-11-08fiscal Q3 201030760001104659-10-056948
10-Q2010-08-05fiscal Q2 201030780001104659-10-042410

Inspect the source

Entity
AMAG PHARMACEUTICALS, INC. / CIK 0000792977
Captured
SEC response SHA-256
d9987b965b5869d8e9b2eeb307cd76b9cd461348ef73e918114383e9479af86a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000792977.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))